Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Nov 15 - Nov 20
This has also been demonstrated clinically [47,48]
I learned that the hard way
Bridons research contributions include: Development of Drug Affinity Complex (DAC) technology for albumin binding and peptide half-life extension Identification and characterization of CJC-1295 as a long-lasting GRF analog with sustained growth hormone-releasing properties Pioneering work on maleimido-derivatized GHRH analogs and their bioconjugation to serum albumin Demonstration of 4-fold increase in growth hormone area-under-curve with optimized CJC-1295 formulation versus native GHRH Extensive in vitro and in vivo pharmacological characterization in rat and human models His 2005 publication in Endocrinology titled Human Growth Hormone-Releasing Factor (hGRF)1-29-Albumin Bioconjugates Activate the GRF Receptor on the Anterior Pituitary in Rats: Identification of CJC-1295 as a Long-Lasting GRF Analog remains the foundational reference for CJC-1295 research, establishing the peptides mechanism of action and pharmacokinetic profile that enabled subsequent clinical investigation
SKU: IPA-5MG Ipamorelin is investigated as a peptide-based research tool for examining selective ghrelin receptor activation, receptor specificity, and growth hormone secretagogue signaling dynamics
US$ 24.74
US$ 25.00
US$ 24.73
US$ 26.73
US$ 28.82
US$ 22.61
